Literature DB >> 29020634

Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer.

Sagar R Shah1, Justin M David2, Nathaniel D Tippens3, Ahmed Mohyeldin4, Juan C Martinez-Gutierrez5, Sara Ganaha6, Paula Schiapparelli6, Duane H Hamilton2, Claudia Palena2, Andre Levchenko7, Alfredo Quiñones-Hinojosa8.   

Abstract

Molecular factors that define stem cell identity have recently emerged as oncogenic drivers. For instance, brachyury, a key developmental transcriptional factor, is also implicated in carcinogenesis, most notably of chordoma, through mechanisms that remain elusive. Here, we show that brachyury is a crucial regulator of stemness in chordoma and in more common aggressive cancers. Furthermore, this effect of brachyury is mediated by control of synthesis and stability of Yes-associated protein (YAP), a key regulator of tissue growth and homeostasis, providing an unexpected mechanism of control of YAP expression. We further demonstrate that the brachyury-YAP regulatory pathway is associated with tumor aggressiveness. These results elucidate a mechanism of controlling both tumor stemness and aggressiveness through regulatory coupling of two developmental factors.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  YAP; brachyury; chordoma; glioblastoma; growth; lung carcinoma; stremness

Mesh:

Substances:

Year:  2017        PMID: 29020634      PMCID: PMC5637538          DOI: 10.1016/j.celrep.2017.09.057

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  90 in total

1.  Chordoma: incidence and survival patterns in the United States, 1973-1995.

Authors:  M L McMaster; A M Goldstein; C M Bromley; N Ishibe; D M Parry
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

Review 2.  T-box genes in early embryogenesis.

Authors:  Chris Showell; Olav Binder; Frank L Conlon
Journal:  Dev Dyn       Date:  2004-01       Impact factor: 3.780

3.  BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.

Authors:  Debalina Sarkar; Brian Shields; Melanie L Davies; Jürgen Müller; Jane A Wakeman
Journal:  Int J Cancer       Date:  2011-05-28       Impact factor: 7.396

4.  Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.

Authors:  Markku Miettinen; Zengfeng Wang; Jerzy Lasota; Christopher Heery; Jeffrey Schlom; Claudia Palena
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

5.  Surgical seeding of chordomas.

Authors:  K I Arnautović; O Al-Mefty
Journal:  J Neurosurg       Date:  2001-11       Impact factor: 5.115

Review 6.  The regulation and function of YAP transcription co-activator.

Authors:  Chu Zhu; Li Li; Bin Zhao
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-12-08       Impact factor: 3.848

Review 7.  Unravelling cancer stem cell potential.

Authors:  Benjamin Beck; Cédric Blanpain
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

8.  The T protein encoded by Brachyury is a tissue-specific transcription factor.

Authors:  A Kispert; B Koschorz; B G Herrmann
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

9.  Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer.

Authors:  Jana Jezkova; Jason S Williams; Filipe Pinto; Stephen J Sammut; Geraint T Williams; Simon Gollins; Ramsay J McFarlane; Rui Manuel Reis; Jane A Wakeman
Journal:  Oncotarget       Date:  2016-03-08

10.  T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma.

Authors:  Ikumi Imajyo; Tsuyoshi Sugiura; Yosuke Kobayashi; Miyuki Shimoda; Kotaro Ishii; Naonari Akimoto; Naoya Yoshihama; Ieyoshi Kobayashi; Yoshihide Mori
Journal:  Int J Oncol       Date:  2012-10-17       Impact factor: 5.650

View more
  17 in total

1.  Verteporfin-Loaded Polymeric Microparticles for Intratumoral Treatment of Brain Cancer.

Authors:  Sagar R Shah; Jayoung Kim; Paula Schiapparelli; Carla A Vazquez-Ramos; Juan C Martinez-Gutierrez; Alejandro Ruiz-Valls; Kyle Inman; James G Shamul; Jordan J Green; Alfredo Quinones-Hinojosa
Journal:  Mol Pharm       Date:  2019-03-11       Impact factor: 4.939

2.  Verteporfin-Loaded Poly(ethylene glycol)-Poly(beta-amino ester)-Poly(ethylene glycol) Triblock Micelles for Cancer Therapy.

Authors:  Jayoung Kim; James G Shamul; Sagar R Shah; Alyssa Shin; Ben J Lee; Alfredo Quinones-Hinojosa; Jordan J Green
Journal:  Biomacromolecules       Date:  2018-07-23       Impact factor: 6.988

Review 3.  New Prospects for Molecular Targets for Chordomas.

Authors:  Mohammad Zeeshan Ozair; Pavan Pinkesh Shah; Dimitrios Mathios; Michael Lim; Nelson S Moss
Journal:  Neurosurg Clin N Am       Date:  2020-01-25       Impact factor: 2.509

4.  Cancer-selective nanoparticles for combinatorial siRNA delivery to primary human GBM in vitro and in vivo.

Authors:  Kristen L Kozielski; Alejandro Ruiz-Valls; Stephany Y Tzeng; Hugo Guerrero-Cázares; Yuan Rui; Yuxin Li; Hannah J Vaughan; Marissa Gionet-Gonzales; Casey Vantucci; Jayoung Kim; Paula Schiapparelli; Rawan Al-Kharboosh; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  Biomaterials       Date:  2019-04-12       Impact factor: 12.479

5.  Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics.

Authors:  James G Shamul; Sagar R Shah; Jayoung Kim; Paula Schiapparelli; Carla A Vazquez-Ramos; Ben J Lee; Kisha K Patel; Alyssa Shin; Alfredo Quinones-Hinojosa; Jordan J Green
Journal:  Int J Nanomedicine       Date:  2019-12-23

6.  Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy.

Authors:  Oluwaseun O Akinduro; Paola Suarez-Meade; Diogo Garcia; Desmond A Brown; Rachel Sarabia-Estrada; Steven Attia; Ziya L Gokaslan; Alfredo Quiñones-Hinojosa
Journal:  Target Oncol       Date:  2021-04-24       Impact factor: 4.864

7.  Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility.

Authors:  Sally Yepes; Nirav N Shah; Jiwei Bai; Hela Koka; Chuzhong Li; Songbai Gui; Mary Lou McMaster; Yanzi Xiao; Kristine Jones; Mingyi Wang; Aurelie Vogt; Bin Zhu; Bin Zhu; Amy Hutchinson; Meredith Yeager; Belynda Hicks; Brian Carter; Neal D Freedman; Laura Beane-Freeman; Stephen J Chanock; Yazhuo Zhang; Dilys M Parry; Xiaohong R Yang; Alisa M Goldstein
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

8.  Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness.

Authors:  Haritha Mathsyaraja; Jonathen Catchpole; Brian Freie; Emily Eastwood; Ekaterina Babaeva; Michael Geuenich; Pei Feng Cheng; Jessica Ayers; Ming Yu; Nan Wu; Sitapriya Moorthi; Kumud R Poudel; Amanda Koehne; William Grady; A McGarry Houghton; Alice H Berger; Yuzuru Shiio; David MacPherson; Robert N Eisenman
Journal:  Elife       Date:  2021-07-08       Impact factor: 8.140

Review 9.  Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms.

Authors:  Oleg Dobrokhotov; Mikhail Samsonov; Masahiro Sokabe; Hiroaki Hirata
Journal:  Clin Transl Med       Date:  2018-08-13

10.  Small-molecule targeting of brachyury transcription factor addiction in chordoma.

Authors:  Tanaz Sharifnia; Mathias J Wawer; Ting Chen; Qing-Yuan Huang; Barbara A Weir; Ann Sizemore; Matthew A Lawlor; Amy Goodale; Glenn S Cowley; Francisca Vazquez; Christopher J Ott; Joshua M Francis; Slim Sassi; Patricia Cogswell; Hadley E Sheppard; Tinghu Zhang; Nathanael S Gray; Paul A Clarke; Julian Blagg; Paul Workman; Josh Sommer; Francis Hornicek; David E Root; William C Hahn; James E Bradner; Kwok K Wong; Paul A Clemons; Charles Y Lin; Joanne D Kotz; Stuart L Schreiber
Journal:  Nat Med       Date:  2019-01-21       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.